TRIM
MDT icon

Thompson Rubinstein Investment Management’s Medtronic MDT Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$4.55M Sell
49,925
-150
-0.3% -$13.4K 1.46% 26
2018
Q4 		$4.55M Sell
50,075
-700
-1% -$65.4K 1.68% 22
2018
Q3 		$5M Sell
50,775
-200
-0.4% -$18.5K 1.53% 27
2018
Q2 		$4.36M Sell
50,975
-95
-0.2% -$7.93K 1.46% 27
2018
Q1 		$4.1M Buy
51,070
+74
+0.1% +$6.1K 1.39% 29
2017
Q4 		$4.12M Sell
50,996
-32
-0.1% -$2.56K 1.36% 30
2017
Q3 		$3.97M Buy
51,028
+350
+0.7% +$29.1K 1.38% 29
2017
Q2 		$4.5M Sell
50,678
-5,500
-10% -$464K 1.66% 23
2017
Q1 		$4.53M Sell
56,178
-1,918
-3% -$150K 1.64% 22
2016
Q4 		$4.14M Buy
58,096
+8,013
+16% +$630K 1.53% 25
2016
Q3 		$4.33M Sell
50,083
-610
-1% -$53.2K 1.64% 23
2016
Q2 		$4.4M Buy
50,693
+665
+1% +$53.8K 1.71% 22
2016
Q1 		$3.75M Hold
50,028
– – 1.53% 26
2015
Q4 		$3.85M Hold
50,028
– – 1.76% 19
2015
Q3 		$3.35M Sell
50,028
-440
-0.9% -$32.4K 1.49% 23
2015
Q2 		$3.74M Sell
50,468
-1,500
-3% -$115K 1.49% 25
2015
Q1 		$4.05M Sell
51,968
-1,575
-3% -$119K 1.59% 22
2014
Q4 		$3.87M Sell
53,543
-2,304
-4% -$160K 1.48% 26
2014
Q3 		$3.46M Sell
55,847
-500
-0.9% -$31.8K 1.36% 29
2014
Q2 		$3.59M Hold
56,347
– – 1.36% 31
2014
Q1 		$3.47M Sell
56,347
-4,575
-8% -$266K 1.39% 32
2013
Q4 		$3.5M Sell
60,922
-200
-0.3% -$11.3K 1.37% 32
2013
Q3 		$3.25M Sell
61,122
-100
-0.2% -$5.38K 1.38% 31
2013
Q2 		$3.15M Buy
+61,222
New +$3.03M 1.42% 28

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Thompson Rubinstein Investment Management's MDT Position: Q1 2019 in Review

Thompson Rubinstein Investment Management reduced its Medtronic (MDT) stake by 0.3% in Q1 2019, selling an estimated $13.4K and leaving 49,925 shares worth $4.55M. The position accounts for 1.46% of the portfolio, ranked #26.

Thompson Rubinstein Investment Management first reported a position in MDT in Q2 2013 and has held it in 24 quarters since. The position peaked at $5M in Q3 2018. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • Thompson Rubinstein Investment Management held 49,925 shares of Medtronic worth $4.55M as of Q1 2019.
  • Thompson Rubinstein Investment Management sold 150 Medtronic shares in Q1 2019, an estimated $13.4K.
  • Medtronic made up 1.46% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #26 holding.
  • Thompson Rubinstein Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 24 quarters since.
  • Thompson Rubinstein Investment Management's Medtronic position peaked at $5M in Q3 2018.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.